These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2784734)

  • 1. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.
    Weetman AP; Cohen S; Gatter KC; Fells P; Shine B
    Clin Exp Immunol; 1989 Feb; 75(2):222-7. PubMed ID: 2784734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy.
    Heufelder AE; Bahn RS
    Clin Exp Immunol; 1993 Mar; 91(3):381-9. PubMed ID: 7680294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L; Norberg R
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens.
    Otto EA; Ochs K; Hansen C; Wall JR; Kahaly GJ
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3045-50. PubMed ID: 8768872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
    J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of immune damage in Graves' ophthalmopathy.
    Hiromatsu Y; Wang PW; Wosu L; How J; Wall JR
    Horm Res; 1987; 26(1-4):198-207. PubMed ID: 3596469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of orbital connective tissue specimens of patients with active Graves ophthalmopathy.
    Avunduk AM; Avunduk MC; Pazarli H; Oguz V; Varnell ED; Kaufman HE; Aksoy F
    Curr Eye Res; 2005 Aug; 30(8):631-8. PubMed ID: 16109642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of ophthalmopathy in autoimmune thyroid disease.
    Heufelder AE
    Rev Endocr Metab Disord; 2000 Jan; 1(1-2):87-95. PubMed ID: 11704996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts.
    Grubeck-Loebenstein B; Trieb K; Sztankay A; Holter W; Anderl H; Wick G
    J Clin Invest; 1994 Jun; 93(6):2738-43. PubMed ID: 8201012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interactions of fibroblasts, adipocytes and immunocompeent cells in the pathogenesis of endocrine ophthalmopathy].
    Heufelder AE
    Acta Med Austriaca; 2001; 28(4):89-92. PubMed ID: 11593897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy.
    Weetman AP; Fells P; Shine B
    Br J Ophthalmol; 1989 May; 73(5):323-7. PubMed ID: 2786428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid-associated eye disease.
    Heufelder AE; Joba W
    Strabismus; 2000 Jun; 8(2):101-11. PubMed ID: 10980691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical evidence for IgA1 involvement in Graves ophthalmopathy.
    Rosen CE; Raikow RB; Burde RM; Kennerdell JS; Mosseri M; Scalise D
    Ophthalmology; 1992 Jan; 99(1):146-52. PubMed ID: 1741128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
    Wu YJ; Clarke EM; Shepherd P
    Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cells.
    Hiromatsu Y; Fukazawa H; How J; Wall JR
    Clin Exp Immunol; 1987 Dec; 70(3):593-603. PubMed ID: 3124997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on pathology and immunoglobulin of orbital tissues from cases with Grave's ophthalmopathy].
    Zhou X; Luo Q; Xia R
    Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):271-3, 18. PubMed ID: 11835820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
    Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
    Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.